1. Home
  2. VERX vs CRSP Comparison

VERX vs CRSP Comparison

Compare VERX & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERX
  • CRSP
  • Stock Information
  • Founded
  • VERX 1978
  • CRSP 2013
  • Country
  • VERX United States
  • CRSP Switzerland
  • Employees
  • VERX N/A
  • CRSP N/A
  • Industry
  • VERX Computer Software: Prepackaged Software
  • CRSP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VERX Technology
  • CRSP Health Care
  • Exchange
  • VERX Nasdaq
  • CRSP Nasdaq
  • Market Cap
  • VERX 5.7B
  • CRSP 5.0B
  • IPO Year
  • VERX 2020
  • CRSP 2016
  • Fundamental
  • Price
  • VERX $25.62
  • CRSP $60.15
  • Analyst Decision
  • VERX Buy
  • CRSP Buy
  • Analyst Count
  • VERX 13
  • CRSP 16
  • Target Price
  • VERX $42.83
  • CRSP $72.27
  • AVG Volume (30 Days)
  • VERX 1.7M
  • CRSP 3.8M
  • Earning Date
  • VERX 08-06-2025
  • CRSP 08-04-2025
  • Dividend Yield
  • VERX N/A
  • CRSP N/A
  • EPS Growth
  • VERX N/A
  • CRSP N/A
  • EPS
  • VERX N/A
  • CRSP N/A
  • Revenue
  • VERX $710,512,000.00
  • CRSP $38,050,000.00
  • Revenue This Year
  • VERX $16.79
  • CRSP $28.31
  • Revenue Next Year
  • VERX $14.63
  • CRSP $268.05
  • P/E Ratio
  • VERX N/A
  • CRSP N/A
  • Revenue Growth
  • VERX 15.00
  • CRSP N/A
  • 52 Week Low
  • VERX $24.45
  • CRSP $30.04
  • 52 Week High
  • VERX $60.71
  • CRSP $71.13
  • Technical
  • Relative Strength Index (RSI)
  • VERX 29.24
  • CRSP 56.00
  • Support Level
  • VERX $24.45
  • CRSP $54.39
  • Resistance Level
  • VERX $26.52
  • CRSP $60.83
  • Average True Range (ATR)
  • VERX 1.30
  • CRSP 3.19
  • MACD
  • VERX -0.52
  • CRSP -0.49
  • Stochastic Oscillator
  • VERX 15.12
  • CRSP 63.92

About VERX Vertex Inc.

Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. Vertex provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting among others. The company derives revenue from software subscriptions.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: